Hostname: page-component-54dcc4c588-ff9ft Total loading time: 0 Render date: 2025-10-13T13:19:05.138Z Has data issue: false hasContentIssue false
  • English
  • Français

Reviewer Comment on Slota et al. “Diagnosis of Creutzfeldt-Jakob Disease in Canada: An Update on Cerebrospinal Fluid Testing from 2016–2024”

Published online by Cambridge University Press:  03 October 2025

Niccolò Candelise Open the ORCID record for Niccolò Candelise [Opens in a new window]  and
Franco Cardone Open the ORCID record for Franco Cardone [Opens in a new window]
Niccolò Candelise
Affiliation:
National Center for Drug Research and Evaluation, Istituto Superiore di Sanità, Rome, Italy
Franco Cardone*
Affiliation:
Core facilities Technical-Scientific Service, Istituto Superiore di Sanità, Rome, Italy
*
Corresponding author: Franco Cardone; Email: franco.cardone@iss.it
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Information

Type
Reviewer Comment
Information
Canadian Journal of Neurological Sciences , First View , pp. 1
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of Canadian Neurological Sciences Federation

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Das, S, Zhang, Z, Ang, LC. Clinicopathological overlap of neurodegenerative diseases: a comprehensive review. J Clin Neurosci. 2020;78:30–33. doi: 10.1016/j.jocn.2020.04.088.CrossRefGoogle ScholarPubMed
Salciccia, C, Costanzo, M, Ruocco, G, et al. Proteopathic seed amplification assays in easily accessible specimens for human synucleinopathies, tauopathies, and prionopathies: a scoping review. Neurosci Biobehav Rev. 2025;169:105997. doi: 10.1016/j.neubiorev.2024.105997.CrossRefGoogle ScholarPubMed
Hermann, P, Appleby, B, Brandel, J-P, et al. Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease. Lancet Neurol. 2021;20:235–246. doi: 10.1016/S1474-4422(20)30477-4.CrossRefGoogle ScholarPubMed
Slota, JA, Myskiw, J, Peterson, A, et al. Diagnosis of Creutzfeldt-Jakob disease in Canada: An update on cerebrospinal fluid testing from 2016–2024. Can J Neurol Sci. 2025;1–23.10.1017/cjn.2025.10088CrossRefGoogle Scholar
Uttley, L, Carroll, C, Wong, R, Hilton, DA, Stevenson, M. Creutzfeldt-Jakob disease: a systematic review of global incidence, prevalence, infectivity, and incubation. Lancet Infect Dis. 2020;20(1):e2–e10. doi: 10.1016/S1473-3099(19)30615-2.CrossRefGoogle ScholarPubMed
Schmitz, M, Candelise, N, Canaslan, S, et al. α-synuclein conformers reveal link to clinical heterogeneity of α-synucleinopathies. Transl Neurodegener. 2023;12(1):12. doi: 10.1186/s40035-023-00342-4.CrossRefGoogle ScholarPubMed